Showing results (91-100 of 135) with videos related to
Sort By:
Pageof 14
Drugs in Context|August 17, 2022
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive diseaseGiulio Metro, Andrea De Giglio, Biagio Ricciuti, et al.Journal of Neuroendocrinology|November 20, 2024
Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogsMichela Polici, Damiano Caruso, Benedetta Masci, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2020
Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non-Small Cell Lung CancerBiagio Ricciuti, Gonzalo Recondo, Liam F Spurr, et al.Cancers|February 24, 2024
Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 PatientsNorma Bonazzi, Emilia Fortunati, Lucia Zanoni, et al.British Journal of Cancer|April 30, 2020
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)Francesco Gelsomino, Marcello Tiseo, Fausto Barbieri, et al.Journal of Clinical Medicine|April 13, 2024
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian CohortFrancesco Panzuto, Elisa Andrini, Giuseppe Lamberti, et al.The Oncologist|February 20, 2019
Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?Enrico Franceschi, Alicia Tosoni, Dario De Biase, et al.The Oncologist|March 13, 2020
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter StudyNicole Brighi, Francesco Panzuto, Roberta Modica, et al.Journal for Immunotherapy of Cancer|May 9, 2025
Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE studyGiuseppe Lamberti, Karim Rihawi, Francesca Mazzoni, et al.Journal of Neurology|February 17, 2023
Peripheral nervous system adverse events associated with immune checkpoint inhibitorsSimone Rossi, Francesco Gelsomino, Rita Rinaldi, et al.Pageof 14